• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Freedom Holding Acquires LD Micro From SRAX, Inc.

    3/6/23 8:00:00 AM ET
    $FRHC
    $SRAX
    Investment Bankers/Brokers/Service
    Finance
    Advertising
    Consumer Discretionary
    Get the next $FRHC alert in real time by email

    Purchase brings pre-eminent small-cap platform to the Freedom family

    Freedom U.S. Markets, LLC, a wholly-owned subsidiary of Freedom Holding Corp. (NASDAQ:FRHC), announced today that it has completed the acquisition of LD Micro from SRAX, Inc. (NASDAQ:SRAX). The total consideration of $8.3 million includes $4 million in cash and FRHC common stock valued at $4.3 million.

    LD Micro offers two premier small-cap conferences annually, the Invitational: June 6-8 (Los Angeles) and the Main Event: October 3-5 (Los Angeles), which hosts over 200 companies and 1,000 investors.

    For the past 15 years, the LD Micro conferences have showcased the next big names in the small-cap world to investors and influencers. In addition, the LD Micro Index provides one of the most accurate representations of the intraday activity of micro-cap stocks in North America.

    "I've admired LD Micro since attending the Main Event in 2018, and I'm thrilled to add them to the Freedom family," said Timur Turlov, CEO of Freedom Holding Corp.

    "Chris Lahiji has created an unparalleled platform to showcase small and micro-cap companies across sectors and geographies," said Robert Wotczak, Chief Executive Officer of Freedom's U.S. operations. "I've known Chris since the beginning and have the utmost respect for him and the LD Micro brand. We see many synergies between LD Micro and the Freedom platform. We look forward to expanding our offering of bespoke and differentiated services to our clients, investors, and stakeholders."

    Chris Lahiji, Founder of LD Micro, commented, "With Freedom, LD takes the world's stage. Our team is ready to showcase what makes us truly special. I am grateful and elated that Mr. Turlov and Mr. Wotczak share our long-term vision and will help us become the standard in the space. We are in the first inning of a very long baseball game."

    SRAX will also serve as the exclusive streaming partner for LD events in the coming years and provide quality coverage for its global audience using the Sequire platform.

    Mitchell Silberberg & Knupp LLP served as legal advisor to SRAX. Ellenoff Grossman & Schole LLP and Morgan, Lewis & Bockius, LLC served as counsel for Freedom.

    About Freedom Holding Corp.

    Freedom Holding Corp., a Nevada corporation, is a financial services holding company conducting retail financial securities brokerage, investment research, investment counseling, securities trading, investment banking and underwriting services, mortgages, insurance, and consumer banking through its subsidiaries under the name of Freedom Finance in Europe and Central Asia. Through its subsidiaries, Freedom Holding Corp. employs more than 2,900 people and is a professional participant in the Kazakhstan Stock Exchange, the Astana International Exchange, the Ukrainian Exchange, the Republican Stock Exchange of Tashkent, and the Uzbek Republican Currency Exchange and is a member of the New York Stock Exchange and the Nasdaq Stock Exchange. Freedom Holding Corp. is headquartered in Almaty, Kazakhstan, and has a presence in 14 countries, including Cyprus, the United States, Uzbekistan, the United Kingdom, and Germany.

    Freedom Holding Corp's common shares are registered with the United States Securities and Exchange Commission and are traded in the United States on the Nasdaq Capital Market, operated by Nasdaq, Inc.

    To learn more about Freedom Holding Corp., visit www.freedomholdingcorp.com.

    About LD Micro

    LD Micro aims to be the most crucial resource in the micro-cap world. Whether it is the index, comprehensive data, or hosting the most significant events annually, LD's sole mission is to serve as an invaluable asset for all those interested in finding the next generation of great companies.

    To learn more about LD Micro, visit http://www.ldmicro.com.

    About SRAX

    SRAX (NASDAQ:SRAX) is a financial technology company that unlocks data and insights for publicly traded companies. Through its premier investor intelligence and communications platform, Sequire, companies can track their investors'; behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX, visit srax.com and mysequire.com.

    Cautionary Note Regarding Forward-Looking Statements

    This release contains "forward-looking" statements. All forward-looking statements are subject to uncertainty and changes in circumstances. In some cases, forward-looking statements can be identified by terminology such as "expect," "new," "plan," "seek," and "will," or the negative of such terms or other comparable terminology used in connection with any discussion of future plans, actions and events. Forward-looking statements are not guarantees of future results or performance and involve risks, assumptions and uncertainties that could cause actual events or results to differ materially from the events or results described in, or anticipated by, the forward-looking statements. Factors that could materially affect such forward-looking statements include certain economic, business, and regulatory risks and factors identified in Freedom Holding Corp.'s periodic and current reports filed with the U.S. Securities and Exchange Commission. All forward-looking statements are made only as of the date of this release and Freedom Holding Corp. assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. Readers should not place undue reliance on these forward-looking statements.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230306005297/en/

    Get the next $FRHC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $FRHC
    $SRAX

    CompanyDatePrice TargetRatingAnalyst
    More analyst ratings

    $FRHC
    $SRAX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • First Trust Financials AlphaDEX becomes the largest shareholders of Freedom Holding after Timur Turlov

      NEW YORK, July 7, 2025 /PRNewswire/ -- As part of its scheduled portfolio rebalancing, the First Trust Financials AlphaDEX Fund (NASDAQ:FXO) acquired 185,000 shares of Freedom Holding Corp. (NASDAQ:FRHC), adding them to its portfolio. As a result of this transaction, the fund has become the second largest shareholder of the company, following its founder and CEO, Timur Turlov. FRHC now holds a 1.22% weighting in the index that underlies the fund's structure. FXO is an exchange-traded fund (ETF) that tracks the performance of the StrataQuant Financials Index. This index include

      7/7/25 3:00:00 PM ET
      $FRHC
      Investment Bankers/Brokers/Service
      Finance
    • S&P Revises Outlook for Freedom Holding Corp. Subsidiaries to Positive

      The outlook upgrade reflects substantial achievements in establishing consolidated risk management and compliance, and strengthening these functions Ratings affirmed for Freedom Finance JSC; Freedom Finance Europe Ltd.; Freedom Finance Global PLC and Freedom Bank Finance Kazakhstan at "B+/B" and for Freedom Holding Corp. at "B-." Outlook for Freedom Holding Corp. subsidiaries revised to positive from stable. Outlook for Freedom Holding Corp. maintained at stable. Freedom Holding Corp. (the "Company") (NASDAQ:FRHC), a multi-national diversified financial services holding company with a presence through its subsidiaries in 22 countries, today commented on S&P Global Ratings ("S&P"

      6/27/25 8:00:00 AM ET
      $FRHC
      Investment Bankers/Brokers/Service
      Finance
    • Freedom Holding Corp. Reports Fiscal Year 2025 Financial Results

      Company Continues Top Line Growth Trend with 23% Increase in Reported Revenue Freedom Holding Corp. (the "Company") (NASDAQ:FRHC), a multinational diversified financial services holding company with a presence in 22 countries, today announced the financial results for their fiscal year 2025. Highlights include the following: $2.05 billion in revenue versus $1.67 billion for the fiscal year 2024, a 23% increase Net income of $1.40 earnings per diluted share; $1.43 per basic share $9.9 billion in total assets as of March 31, 2025 Headcount of 8,764 as of March 31, 2025 Fiscal 2025 Financial Highlights: The Company recognized revenue of approximately $2.05 billion in fiscal

      6/13/25 5:22:00 PM ET
      $FRHC
      Investment Bankers/Brokers/Service
      Finance

    $FRHC
    $SRAX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President Tashtitov Askar was granted 5,691 shares, increasing direct ownership by 4% to 142,899 units (SEC Form 4)

      4 - Freedom Holding Corp. (0000924805) (Issuer)

      7/11/25 7:51:43 AM ET
      $FRHC
      Investment Bankers/Brokers/Service
      Finance
    • Chief Financial Officer Ler Evgeny was granted 5,169 shares, increasing direct ownership by 15% to 39,077 units (SEC Form 4)

      4 - Freedom Holding Corp. (0000924805) (Issuer)

      7/11/25 7:48:28 AM ET
      $FRHC
      Investment Bankers/Brokers/Service
      Finance
    • Officer Lukyanov Sergey bought $1,001,974 worth of shares (6,900 units at $145.21), increasing direct ownership by 6% to 126,700 units (SEC Form 4)

      4 - Freedom Holding Corp. (0000924805) (Issuer)

      7/2/25 4:21:07 PM ET
      $FRHC
      Investment Bankers/Brokers/Service
      Finance

    $FRHC
    $SRAX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • June 7, 2024 - FDA Roundup: June 7, 2024

      For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

      6/7/24 3:46:22 PM ET
      $GERN
      $SRAX
      $SNAP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Advertising
      Consumer Discretionary
    • March 22, 2024 - FDA Roundup: March 22, 2024

      For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

      3/22/24 5:02:42 PM ET
      $SNAP
      $SRAX
      Computer Software: Programming Data Processing
      Technology
      Advertising
      Consumer Discretionary
    • November 9, 2023 - FDA Approves First Treatment for Patients with Rare Inherited Blood Clotting Disorder

      For Immediate Release: November 09, 2023 Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder. “The FDA remains

      11/9/23 2:30:20 PM ET
      $SRAX
      $SNAP
      Advertising
      Consumer Discretionary
      Computer Software: Programming Data Processing
      Technology

    $FRHC
    $SRAX
    SEC Filings

    See more
    • SEC Form 10-K filed by Freedom Holding Corp.

      10-K - Freedom Holding Corp. (0000924805) (Filer)

      6/13/25 4:31:08 PM ET
      $FRHC
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form NT 10-K filed by Freedom Holding Corp.

      NT 10-K - Freedom Holding Corp. (0000924805) (Filer)

      5/30/25 4:08:30 PM ET
      $FRHC
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form 10-Q filed by SRAX Inc.

      10-Q - SRAX, Inc. (0001538217) (Filer)

      4/30/25 6:18:31 AM ET
      $SRAX
      Advertising
      Consumer Discretionary

    $FRHC
    $SRAX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Lukyanov Sergey bought $1,001,974 worth of shares (6,900 units at $145.21), increasing direct ownership by 6% to 126,700 units (SEC Form 4)

      4 - Freedom Holding Corp. (0000924805) (Issuer)

      7/2/25 4:21:07 PM ET
      $FRHC
      Investment Bankers/Brokers/Service
      Finance
    • President Tashtitov Askar bought $84,450 worth of shares (600 units at $140.75), increasing direct ownership by 0.44% to 137,208 units (SEC Form 4)

      4 - Freedom Holding Corp. (0000924805) (Issuer)

      6/20/25 4:02:14 PM ET
      $FRHC
      Investment Bankers/Brokers/Service
      Finance
    • Miglino Christopher bought $750 worth of SRAX Common Stock (15,000 units at $0.05), increasing direct ownership by 2% to 902,575 units (SEC Form 4)

      4 - SRAX, Inc. (0001538217) (Issuer)

      12/28/23 5:25:44 PM ET
      $SRAX
      Advertising
      Consumer Discretionary

    $FRHC
    $SRAX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Dawson James initiated coverage on SRAX with a new price target

      Dawson James initiated coverage of SRAX with a rating of Buy and set a new price target of $10.00

      4/19/21 9:31:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • B. Riley reiterated coverage on SRAX with a new price target

      B. Riley reiterated coverage of SRAX with a rating of Buy and set a new price target of $7.50 from $4.50 previously

      2/12/21 8:22:29 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • Ladenburg Thalmann initiated coverage on SRAX with a new price target

      Ladenburg Thalmann initiated coverage of SRAX with a rating of Buy and set a new price target of $7.00

      2/8/21 7:58:16 AM ET
      $SRAX
      Advertising
      Consumer Discretionary

    $FRHC
    $SRAX
    Leadership Updates

    Live Leadership Updates

    See more
    • June 7, 2024 - FDA Roundup: June 7, 2024

      For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

      6/7/24 3:46:22 PM ET
      $GERN
      $SRAX
      $SNAP
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Advertising
      Consumer Discretionary
    • SRAX Announces Appointment of New CFO

      Los Angeles, California--(Newsfile Corp. - March 20, 2023) - SRAX, Inc. (NASDAQ:SRAX), a leading financial technology company, has announced the appointment of Alan Urban as the CFO of SRAX. Mr. Urban has over 30 years of experience in corporate finance and accounting. He has previously served in numerous senior management positions, most notably as Chief Financial Officer for ten years at Research Solutions, a provider of SaaS solutions for life science organizations. Mr. Urban also serves on the Board of Directors of GT Biopharma."We are excited to have Alan step into this very important role at SRAX. We believe his 30 years of expertise will be instrumental in getting our accounting t

      3/20/23 9:00:00 AM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • Jon V. Rogers Joins Freedom Capital Markets

      Citigroup Veteran Named Freedom Executive Vice President Appointment Recognizes Leadership and Contributions to Future Growth Freedom Capital Markets (FCM), the investment banking and equity capital markets arm of Prime Executions, Inc., a wholly-owned subsidiary of Freedom Holding Corp. (NASDAQ:FRHC) is pleased to announce the appointment of Citigroup veteran Jon V. Rogers as Executive Vice President and a member of FCM's Management and Investment Committees. "Jon will play a pivotal role in all strategic initiatives as we continue to expand Freedom's U.S. footprint and offerings. His experience analyzing equity transactions at Citi will also be very beneficial as we build out our inves

      11/16/22 7:30:00 AM ET
      $FRHC
      Investment Bankers/Brokers/Service
      Finance

    $FRHC
    $SRAX
    Financials

    Live finance-specific insights

    See more
    • Freedom Holding Corp. Reports Fiscal Year 2025 Financial Results

      Company Continues Top Line Growth Trend with 23% Increase in Reported Revenue Freedom Holding Corp. (the "Company") (NASDAQ:FRHC), a multinational diversified financial services holding company with a presence in 22 countries, today announced the financial results for their fiscal year 2025. Highlights include the following: $2.05 billion in revenue versus $1.67 billion for the fiscal year 2024, a 23% increase Net income of $1.40 earnings per diluted share; $1.43 per basic share $9.9 billion in total assets as of March 31, 2025 Headcount of 8,764 as of March 31, 2025 Fiscal 2025 Financial Highlights: The Company recognized revenue of approximately $2.05 billion in fiscal

      6/13/25 5:22:00 PM ET
      $FRHC
      Investment Bankers/Brokers/Service
      Finance
    • Freedom Holding Corp. Reports Strong Revenue Growth in Q3 2025 Fiscal Year, Driven by Brokerage and Banking Segments

      NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Freedom Holding Corp. (NASDAQ:FRHC), a U.S.-based financial services company, has announced its financial results for the quarter ended December 31, 2024. The holding company reported a 57% increase in total revenue, with revenues reaching $655.2 million compared to $418.6 million in the same quarter of 2023. Total assets increased to $9.1 billion from $8.3 billion as of March 31, 2024. The company's revenue has surged due to the increase of net gain on trading securities, which has risen from a $5.1 million loss to a $89.6 million gain. Additionally, company's performance was significantly bolstered by its insurance underwriti

      2/7/25 9:33:30 AM ET
      $FRHC
      Investment Bankers/Brokers/Service
      Finance
    • Freedom Holding Corp. Reports Fiscal Year 2024 Financial Results

      Company Reports Record Year, With 105% Increase in Reported RevenuesALMATY, KAZAKHSTAN / ACCESSWIRE / June 14, 2024 / Freedom Holding Corp. (NASDAQ:FRHC) ("Freedom", or the "Company"), a multi-national diversified financial services holding company with a presence through its subsidiaries in 20 countries, today announced its financial results for the 12 months ended March 31, 2024, or fiscal 2024. Fiscal 2024 Highlights:Revenue totaled approximately $1.6 billion compared to $796 million for the prior fiscal year, an increase of 105%, primarily attributable to an increase in interest income, fee and commission income, and insurance underwriting income.Fee and commission income was $440 mill

      6/14/24 5:00:00 PM ET
      $FRHC
      Investment Bankers/Brokers/Service
      Finance

    $FRHC
    $SRAX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by SRAX Inc. (Amendment)

      SC 13G/A - SRAX, Inc. (0001538217) (Subject)

      2/14/24 2:56:29 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SEC Form SC 13G/A filed by SRAX Inc. (Amendment)

      SC 13G/A - SRAX, Inc. (0001538217) (Subject)

      2/13/24 7:42:04 PM ET
      $SRAX
      Advertising
      Consumer Discretionary
    • SEC Form SC 13G/A filed by SRAX Inc. (Amendment)

      SC 13G/A - SRAX, Inc. (0001538217) (Subject)

      2/14/23 3:07:08 PM ET
      $SRAX
      Advertising
      Consumer Discretionary